Researchers find biomarker for early onset GVHD after transplant

01/8/2010 | Science News

Researchers have discovered that a protein called elafin showed up in greater concentrations among bone marrow transplant patients who exhibited a skin rash after the procedure and developed graft-versus-host disease later on compared with those who did not develop the disease. The new protein biomarker could help determine whether skin rash is a sign of early developing GVHD after bone marrow transplant, as well as identify the patients who need more aggressive treatment, the researchers said.

View Full Article in:

Science News

Published in Brief:

SmartBrief Job Listings for Health Care